0000899866-17-000157.txt : 20170830
0000899866-17-000157.hdr.sgml : 20170830
20170830181311
ACCESSION NUMBER: 0000899866-17-000157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170828
FILED AS OF DATE: 20170830
DATE AS OF CHANGE: 20170830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Julie
CENTRAL INDEX KEY: 0001630299
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 171061640
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 2032722596
MAIL ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
wf-form4_150413117771204.xml
FORM 4
X0306
4
2017-08-28
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001630299
O'Neill Julie
C/O ALEXION PHARMACEUTICALS, INC
100 COLLEGE STREET
NEW HAVEN
CT
06510
0
1
0
0
EVP. Global Operations
Common Stock, par value $.0001 per share
2017-08-28
4
S
0
11160
140
D
26704
D
The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
/s/ Michael Greco, Attorney-in-Fact for Julie O'Neill
2017-08-30